Calendar

A Pre-Approval Information Exchange (PIE) Webinar sponsored by Otsuka America Pharmaceutical, Inc. and Lundbeck LLC.

Agitation associated with Alzheimer's dementia (AAD) imposes a significant clinical, humanistic, and economic burden to patients, caregivers, & society. There is currently no approved
medication for the treatment of AAD in the US.

This session will cover the safety & efficacy data of an investigational treatment for AAD.

Speaker:

• Madeline Shurtleff, PharmD
  Managed Market Liaison, Field Medical Affairs at Otsuka America Pharmaceutical, Inc.

This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions^®.

Despite optimization of carbidopa/levodopa and addition of ON-extender therapies, patients with Parkinson’s disease may still experience significant daily OFF time. Complementary use of on-demand treatments may provide benefit when OFF episodes occur.  

This webinar will review the impact of OFF episodes, the treatment paradigm for OFF episodes, and the place in therapy for on-demand treatments.